Laurie DiModica leads Clarivate’s Global Access Advisory Service. She has more than 20 years’ experience providing insights to clients in global healthcare and biopharmaceutical markets. For the past 12 years, her work has focused on market access strategy within the major and emerging markets for biopharmaceuticals, medical technologies and digital therapeutics, covering a broad range of therapeutic areas including oncology, immune/inflammatory disorders, cardiovascular diseases, central nervous system (CNS) disorders, rare/orphan diseases, and others.
She has served as a Principal Analyst within the Decision Resources Group (now Clarivate) Access & Reimbursement product team, where she conducted hundreds of primary research interviews to provide insights into the company’s advisory reports for the US, EU and LATAM markets. Her work for Clarivate includes several years of commercial forecasting and pipeline assessments.
She previously served as a Medical Publications & Conference Director for the Institute for International Research (IIR), specializing in the U.S. managed care market. Laurie has an M.S. from Simmons College in Boston, MA.